ANNA REZNIKOVA: Open Payments
NPI 1639474927 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,862 in 83 payments from 22 companies in 2025. Trend: 2023 $1,302 · 2024 $2,312 · 2025 $1,862
Food & beverage: $1,862
| Company | Payments | Amount |
|---|---|---|
| Botanix SB Inc | 9 | $253 |
| Janssen Biotech, Inc. | 16 | $246 |
| GENZYME CORPORATION | 5 | $213 |
| ABBVIE INC. | 11 | $193 |
| Organon LLC | 5 | $119 |
| Incyte Corporation | 5 | $116 |
| Lilly USA, LLC | 3 | $81 |
| UCB, Inc. | 3 | $77 |
| Regeneron Healthcare Solutions, Inc. | 4 | $74 |
| LEO Pharma Inc. | 3 | $71 |
Products named: DUPIXENT, SOFDRA, TREMFYA, SKYRIZI, OPZELURA, TALTZ, Bimzelx, CIBINQO.
Industry payments across MD — which companies pay providers there.
